Medication Abortion Via Pharmacy Dispensing
Completed · Phase 4
Conditions studied: Pregnancy Related, Abortion Early
In brief
This mixed-methods study follows a prospective cohort of patients receiving Mifeprex ® (mifepristone) for medication abortion dispensed by pharmacists after undergoing standard clinical evaluation. Women participating in this study will obtain mifepristone and misoprostol from the pharmacy instead of in the clinic. To assess feasibility, acceptability, and effectiveness of pharmacy dispensing of mifepristone, the study will survey patients, evaluate their clinical outcomes from electronic health records, and survey and interview pharmacists at study sites.
Key facts
- Study ID
- NCT03320057
- Run by
- Daniel Grossman
- People needed
- 326
- Starts
- 2018-06-01
- Expected to finish
- 2020-07-04
- Last updated by the study team
- 2021-07-12
Who can join
Age: 15 and older. Sex: female. Healthy volunteers: accepted.
Where it is running
- Obstetrics and Gynecology Family Planning Clinic at University of California Davis — Sacramento, California, United States
- Women's Health Services at University of California San Diego — San Diego, California, United States
- Kaiser Permanente Northern California — San Francisco, California, United States
- Mt. Zion Women's Options Clinic, University — San Francisco, California, United States
- University of Washington — Seattle, Washington, United States
- Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.